Published in J Vasc Surg on November 01, 2004
Transient elastic support for vein grafts using a constricting microfibrillar polymer wrap. Biomaterials (2008) 1.10
Coronary artery bypass grafting hemodynamics and anastomosis design: a biomedical engineering review. Biomed Eng Online (2013) 0.91
Neointima development in externally stented saphenous vein grafts. Postepy Kardiol Interwencyjnej (2016) 0.84
Procedure for human saphenous veins ex vivo perfusion and external reinforcement. J Vis Exp (2014) 0.81
Expandable external support device to improve Saphenous Vein Graft Patency after CABG. J Cardiothorac Surg (2013) 0.79
Reduced intimal hyperplasia in rabbits via medical therapy after carotid venous bypass. Tex Heart Inst J (2009) 0.76
Folic acid administration reduces neointimal thickening, augments neo-vasa vasorum formation and reduces oxidative stress in saphenous vein grafts from pigs used as a model of diabetes. Diabetologia (2010) 0.76
Administration of perivascular cyanoacrylate for the prevention of cellular damage in saphenous vein grafts: an experimental model. Cardiovasc J Afr (2015) 0.75
Novel no touch technique of saphenous vein harvesting: Is great graft patency rate provided? Ann Card Anaesth (2016) 0.75
Biomaterial-Based Approaches to Address Vein Graft and Hemodialysis Access Failures. Macromol Rapid Commun (2016) 0.75
Biaxial Stretch Improves Elastic Fiber Maturation, Collagen Arrangement, and Mechanical Properties in Engineered Arteries. Tissue Eng Part C Methods (2016) 0.75
Short-term effects of double-layer autologous vein graft on restraint of excessive distension and alleviation of neointimal hyperplasia in a porcine saphenous vein graft model. Heart Vessels (2010) 0.75
Liberal or restrictive transfusion after cardiac surgery. N Engl J Med (2015) 6.69
Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation (2007) 5.31
Control chart methods for monitoring cardiac surgical performance and their interpretation. J Thorac Cardiovasc Surg (2004) 3.02
Effect of body mass index on early outcomes in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol (2003) 2.87
Combined clopidogrel and aspirin treatment up to surgery increases the risk of postoperative myocardial infarction, blood loss and reoperation for bleeding in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg (2012) 2.69
Assessment of unstable atherosclerosis in mice. Arterioscler Thromb Vasc Biol (2007) 2.49
TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest (2010) 2.32
Radial versus right internal thoracic artery as a second arterial conduit for coronary surgery: early and midterm outcomes. J Thorac Cardiovasc Surg (2003) 2.29
Effect of adding postoperative noninvasive ventilation to usual care to prevent pulmonary complications in patients undergoing coronary artery bypass grafting: a randomized controlled trial. J Thorac Cardiovasc Surg (2013) 2.18
Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol (2009) 1.78
Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. J Clin Invest (2011) 1.70
Retinal and cerebral microembolization during coronary artery bypass surgery: a randomized, controlled trial. Circulation (2005) 1.68
Pulmonary injury after cardiopulmonary bypass: beneficial effects of low-frequency mechanical ventilation. J Thorac Cardiovasc Surg (2009) 1.60
On-pump and off-pump coronary artery bypass grafting in patients with left main stem disease: a propensity score analysis. J Thorac Cardiovasc Surg (2011) 1.55
Evaluation of the effectiveness of off-pump coronary artery bypass grafting in high-risk patients: an observational study. Ann Thorac Surg (2002) 1.53
Effects of preoperative statin treatment on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Ann Thorac Surg (2009) 1.51
A clinical score to predict the need for intraaortic balloon pump in patients undergoing coronary artery bypass grafting. Ann Thorac Surg (2010) 1.50
Retrograde hot-shot cardioplegia in patients with left ventricular hypertrophy undergoing aortic valve replacement. Ann Thorac Surg (2008) 1.48
Interactive effects of homocysteine and copper on angiogenesis in porcine isolated saphenous vein. Ann Thorac Surg (2007) 1.48
Coronary artery bypass grafting on the beating heart: surgical revascularization for the next decade? Eur Heart J (2004) 1.48
Prevention of post-cardiopulmonary bypass acute kidney injury by endothelin A receptor blockade. Crit Care Med (2011) 1.48
Differential, time-dependent effects of perivenous application of fibrin glue on medial thickening in porcine saphenous vein grafts. Eur J Cardiothorac Surg (2006) 1.46
Phosphodiesterase-5 inhibition prevents postcardiopulmonary bypass acute kidney injury in swine. Ann Thorac Surg (2011) 1.46
Embolic protection device utilization during stenting of native coronary artery lesions with large lipid core plaques as detected by near-infrared spectroscopy. Catheter Cardiovasc Interv (2012) 1.46
Training residents in off-pump coronary artery bypass surgery: a 14-year experience. J Thorac Cardiovasc Surg (2011) 1.44
Off-pump coronary artery bypass grafting: for the many or the few? J Thorac Cardiovasc Surg (2010) 1.42
Coronary collateral circulation: effect on early and midterm outcomes after off-pump coronary artery bypass surgery. Ann Thorac Surg (2008) 1.42
Effect of normothermic cardiopulmonary bypass on renal injury in pediatric cardiac surgery: a randomized controlled trial. J Thorac Cardiovasc Surg (2011) 1.41
Mild renal dysfunction in patients undergoing cardiac surgery as a new risk factor for EuroSCORE. Heart (2010) 1.40
Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts. J Thorac Cardiovasc Surg (2007) 1.39
Saphenous vein harvest with the Mayo extraluminal dissector: is endothelial function preserved? J Thorac Cardiovasc Surg (2008) 1.39
Early and midterm clinical outcome in patients with severe left ventricular dysfunction undergoing coronary artery surgery. Ann Thorac Surg (2003) 1.39
Genomics of foam cells and nonfoamy macrophages from rabbits identifies arginase-I as a differential regulator of nitric oxide production. Arterioscler Thromb Vasc Biol (2006) 1.28
Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes. Thromb Haemost (2009) 1.24
Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass. Exp Biol Med (Maywood) (2005) 1.24
Wnt4/β-catenin signaling induces VSMC proliferation and is associated with intimal thickening. Circ Res (2010) 1.24
Dismantling of cadherin-mediated cell-cell contacts modulates smooth muscle cell proliferation. Circ Res (2003) 1.23
Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells. J Vasc Res (2008) 1.15
Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor? Atherosclerosis (2006) 1.15
Animal models of spontaneous plaque rupture: the holy grail of experimental atherosclerosis research. Curr Atheroscler Rep (2002) 1.14
Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review. Heart Fail Rev (2011) 1.12
Myocardial protection with intermittent cold blood during aortic valve operation: antegrade versus retrograde delivery. Ann Thorac Surg (2003) 1.11
Iloprost inhibits superoxide formation and gp91phox expression induced by the thromboxane A2 analogue U46619, 8-isoprostane F2alpha, prostaglandin F2alpha, cytokines and endotoxin in the pig pulmonary artery. Br J Pharmacol (2004) 1.10
Sildenafil inhibits the formation of superoxide and the expression of gp47 NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells. BJU Int (2005) 1.10
Beating heart against cardioplegic arrest studies (BHACAS 1 and 2): quality of life at mid-term follow-up in two randomised controlled trials. Eur Heart J (2004) 1.10
R-cadherin:beta-catenin complex and its association with vascular smooth muscle cell proliferation. Arterioscler Thromb Vasc Biol (2004) 1.08
Splanchnic organ injury during coronary surgery with or without cardiopulmonary bypass: a randomized, controlled trial. Ann Thorac Surg (2006) 1.06
Soluble N-cadherin overexpression reduces features of atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol (2008) 1.04
Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-κB. PLoS One (2012) 1.03
Towards the treatment of saphenous vein bypass graft failure--a perspective of the Bristol Heart Institute. Biorheology (2002) 1.03
Morbidity and mortality following acute conversion from off-pump to on-pump coronary surgery. Eur J Cardiothorac Surg (2006) 1.02
Role of colony-stimulating factors in atherosclerosis. Curr Opin Lipidol (2012) 1.02
Characterization of the differential response of endothelial cells exposed to normal and elevated laminar shear stress. J Cell Physiol (2011) 0.99
Reactive oxygen species, vascular disease and cardiovascular surgery. Curr Vasc Pharmacol (2004) 0.99
Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats. BJU Int (2009) 0.98
Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy. Circulation (2011) 0.98
Sildenafil citrate and sildenafil nitrate (NCX 911) are potent inhibitors of superoxide formation and gp91phox expression in porcine pulmonary artery endothelial cells. Br J Pharmacol (2005) 0.98
Off-pump coronary artery bypass grafting: not a flash in the pan. Ann Thorac Surg (2003) 0.98
Transcriptomic analysis of patients with tetralogy of Fallot reveals the effect of chronic hypoxia on myocardial gene expression. J Thorac Cardiovasc Surg (2010) 0.98
Bedside tool for predicting the risk of postoperative atrial fibrillation after cardiac surgery: the POAF score. J Am Heart Assoc (2014) 0.96
Concise review: MicroRNAs as modulators of stem cells and angiogenesis. Stem Cells (2014) 0.95
Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits. Eur J Pharmacol (2005) 0.95
Group A streptococcal puerperal sepsis: initial characterization of virulence factors in association with clinical parameters. J Reprod Immunol (2009) 0.95
MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis. Cardiovasc Res (2010) 0.94
Periadventitial rapamycin-eluting microbeads promote vein graft disease in long-term pig vein-into-artery interposition grafts. Circ Cardiovasc Interv (2010) 0.93
Oxidative stress, nitric oxide, and vascular disease. J Card Surg (2003) 0.93
The effect of diabetes mellitus on patients undergoing coronary surgery: a risk-adjusted analysis. J Thorac Cardiovasc Surg (2006) 0.92
On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents. Biomaterials (2006) 0.92
Superoxide auto-augments superoxide formation and upregulates gp91(phox) expression in porcine pulmonary artery endothelial cells: inhibition by iloprost. Eur J Pharmacol (2006) 0.92
An open randomized controlled trial of median sternotomy versus anterolateral left thoracotomy on morbidity and health care resource use in patients having off-pump coronary artery bypass surgery: the Sternotomy Versus Thoracotomy (STET) trial. J Thorac Cardiovasc Surg (2012) 0.92
Interactions between thromboxane A₂, thromboxane/prostaglandin (TP) receptors, and endothelium-derived hyperpolarization. Cardiovasc Res (2014) 0.92
Thoracic endovascular repair versus open surgical repair - which is the more cost-effective intervention for descending thoracic aortic pathologies? Eur J Cardiothorac Surg (2011) 0.91
Predictors of new malignant ventricular arrhythmias after coronary surgery: a case-control study. J Am Coll Cardiol (2004) 0.90
Transforming growth factor-beta is activated by plasmin and inhibits smooth muscle cell death in human saphenous vein. J Vasc Res (2005) 0.90
A randomized trial of an external Dacron sheath for the prevention of vein graft disease: the Extent study. J Thorac Cardiovasc Surg (2007) 0.90